Skip to content
Healthcare on the African continent is changing. “At the current pace, the annual rate of cancer in Africa is projected to reach 1.4 million […]
How do we achieve the cancer moonshot in Africa? Read More »
Psychedelics have established themselves as a game changer in the drug development space in recent years. And it is not just scientists who are
Psychedelics ‘do things in the brain that nothing else does’ Read More »
Andrew Marshall’s life turned upside down when he was 16 and received an acute lymphoblastic leukemia diagnosis. As a budding musician, he would sit
The ultimate collaboration: Make-A-Wish Foundation and biotech Read More »
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation
How can we increase routine adult vaccination? Read More »
The disease burden of RSV has been a tough problem for biotech R&D to solve for over 60 years. However, within the last year,
We’re conquering RSV for the young and old – but more innovation is needed Read More »
The Accelerated Approval pathway has helped deliver groundbreaking treatments to patients—including for diseases like HIV. But lately, the pathway has faced increased pressure, threatening
What’s at stake for Accelerated Approval? Read More »
Cancer is less the death sentence that it used to be. That does not mean that cancer treatment can’t be profoundly life-altering or that
NIH Innovation Zone: Meet Privo Technologies Read More »
Lessons from COVID, the Inflation Reduction Act (IRA), drug prices, drug shortages, Accelerated Approval and a lawsuit seeking to block use of an approved
FDA Commissioner Califf on COVID lessons, Accelerated Approval, and more Read More »
Patient stories and relationships are at the heart of state advocacy. “A lot of policymakers are just not aware of what our companies are,
How to build a state or regional advocacy arm Read More »
On June 6, the 2023 Biotechnology Innovation Organization (BIO) International Convention opened with remarks by Katie Couric who, in addition to being an award-winning
Katie Couric on patient advocacy, breast cancer, and biotech Read More »
